Ep135: John Maraganore on Developing a New Class of Medicines
The Long Run with Luke Timmerman
00:00
Path to CEO and founding Alnylam
John tells how Atlas Ventures recruited him and how he became founding CEO of Alnylam to pursue RNAi therapeutics.
Play episode from 15:06
Transcript
